…
Zero Candida Technologies, Inc., a technology company, designs, develops, manufactures, and sells non-drug blue light therapy devices for the treatment of vulvo-vaginal candidiasis. It offers Zero Candida, a smart vaginal diagnostic device that collects and transmits treatment data to the attending physician in real time for assessment, treatment, personalization, and monitoring. The company is headquartered in Vancouver, Canada.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Zero Candida Technologies Inc. is a publicly listed company on the TSX Venture Exchange (ZCT); public disclosures provide limited detail on its operations and product portfolio. Long-term growth will depend on clarifying strategy, executing initiatives, securing financing and achieving market adoption; investors may find potential upside if management delivers verifiable milestones.
Key risks include limited disclosure, execution and financing risk, low liquidity and regulatory or clinical hurdles if the company operates in health-related markets.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Type | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 |
| Income before tax | -6.28M | -0.01M |
| Net income | -6.28M | -0.01M |
| Selling general administrative | 0.96M | 0.01M |
| Operating income | -2.24M | -0.01M |
| Interest expense | 0.14M | - |
| Interest income | 0.10M | - |
| Net interest income | -0.04M | - |
| Total revenue | 0.00M | 0.00M |
| Total operating expenses | 2.24M | 0.01M |
| Total other income expense net | -4.00M | - |
| Net income from continuing ops | -6.28M | -0.01M |
| Breakdown | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Type | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 |
| Total assets | 3.21M | 0.00M |
| Total liab | 0.87M | 0.03M |
| Total stockholder equity | 2.34M | -0.02M |
| Capital stock | 0.20M | 0.04M |
| Retained earnings | -10.48M | -0.06M |
| Cash | 0.24M | 0.00M |
| Total current liabilities | 0.84M | 0.03M |
| Net debt | 0.00M | 0.00M |
| Short long term debt | 0.01M | 0.01M |
| Total current assets | 3.19M | 0.00M |
| Short term investments | 2.81M | - |
| Accounts payable | 0.00M | - |
| Non current assets total | 0.03M | 0.00M |
| Capital lease obligations | 0.03M | - |
| Breakdown | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Type | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 |
| Investments | -1.35M | - |
| Net borrowings | 0.00M | - |
| Total cash from financing activities | 2.55M | - |
| Net income | -6.28M | -0.01M |
| Change in cash | 0.27M | -0.01M |
| Begin period cash flow | 0.17M | 0.01M |
| End period cash flow | 0.24M | 0.00M |
| Total cash from operating activities | -0.94M | -0.01M |
| Issuance of capital stock | 2.55M | - |
| Capital expenditures | 0.00M | 0.00M |
| Change in working capital | 0.01M | 0.01M |
| Other non cash items | 5.34M | - |
| Free cash flow | -0.94M | -0.01M |
Sector: Healthcare Industry: Medical Devices
|
Stock Name
|
Change
(CAD) |
Price
(CAD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
|---|---|---|---|---|---|---|
| ZCT Zero Candida Technologies Inc. |
- -% |
0.14 | - | - | - | 2.27 |
| TLT Theralase Technologies Inc. |
0.01 5.56% |
0.19 | - | - | 90.07 | 82.51 |
| CNVI Conavi Medical Corp. |
-0.01 4.35% |
0.11 | - | - | 66.65 | - |
| PINK Perimeter Medical Imaging AI Inc |
-0.01 5.56% |
0.17 | 4.13 | - | 18.78 | 11.34 |
| CHER Cheelcare Inc. |
- -% |
1.25 | - | - | 20.92 | 106.42 |
Zero Candida Technologies, Inc., a technology company, designs, develops, manufactures, and sells non-drug blue light therapy devices for the treatment of vulvo-vaginal candidiasis. It offers Zero Candida, a smart vaginal diagnostic device that collects and transmits treatment data to the attending physician in real time for assessment, treatment, personalization, and monitoring. The company is headquartered in Vancouver, Canada.
666 Burrard Street, Vancouver, BC, Canada, V6C 3P6
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.